EUDA Health Holdings Operating Income 2022-2023 | EUDA

EUDA Health Holdings operating income from 2022 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
EUDA Health Holdings Annual Operating Income
(Millions of US $)
2022 $-12
2021 $-1
EUDA Health Holdings Quarterly Operating Income
(Millions of US $)
2023-06-30
2023-03-31 $-2
2022-12-31
2022-03-31 $0
2021-12-31
2021-10-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.046B $0.010B
EUDA Health Limited is a health technology company which operates southeast Asian digital healthcare ecosystem. The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions and aftercare services. EUDA Health Limited, formerly known as 8i Acquisition 2 Corp., is based in Singapore.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.723B 19.61
Inspire Medical Systems (INSP) United States $7.393B 0.00
IRhythm Technologies (IRTC) United States $3.477B 0.00
Axonics (AXNX) United States $3.412B 0.00
10x Genomics (TXG) United States $3.208B 0.00
Enovis (ENOV) United States $3.038B 23.08
Azenta (AZTA) United States $2.905B 236.82
Olink Holding AB (publ) (OLK) Sweden $2.820B 0.00
Hims & Hers Health (HIMS) United States $2.680B 0.00
Privia Health (PRVA) United States $2.139B 94.89
Schrodinger (SDGR) United States $1.827B 0.00
Omnicell (OMCL) United States $1.248B 30.53
Phreesia (PHR) United States $1.185B 0.00
Definitive Healthcare (DH) United States $0.821B 0.00
Standard BioTools (LAB) United States $0.737B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.680B 0.00
Fulgent Genetics (FLGT) United States $0.619B 0.00
Talkspace (TALK) United States $0.536B 0.00
Health Catalyst (HCAT) United States $0.373B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.329B 0.00
Clover Health Investments (CLOV) United States $0.318B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
P3 Health Partners (PIII) United States $0.183B 0.00
Butterfly Network (BFLY) United States $0.164B 0.00
American Well (AMWL) United States $0.154B 0.00
Outset Medical (OM) United States $0.147B 0.00
MSP Recovery (LIFW) United States $0.129B 0.00
Augmedix (AUGX) United States $0.124B 0.00
TruBridge (TBRG) United States $0.118B 5.04
111 (YI) China $0.088B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
Movano (MOVE) United States $0.048B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Akili (AKLI) United States $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.025B 0.00
Cue Health (HLTH) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00